The Regional Minister of Health inaugurates the UBICEC, a new key infrastructure for clinical trials in the Balearic Islands with an investment of 1.2 million euros.
The new infrastructure will allow access to innovative treatments without having to travel outside the archipelago and offer new therapeutic opportunities.
The Regional Minister of Health, Manuela García Romero, today inaugurated the Balearic Islands Clinical Research and Clinical Trials Unit (UBICEC) at the Son Espases University Hospital. This new infrastructure will allow clinical trials in the early stages of the development of new treatments (Phase I and II) and will provide patients with earlier access to innovative therapies.
TDB keeps you informed. Follow us on: Facebook, Twitter and Instagram
The Balearic Unit for Clinical Research and Clinical Trials (UBICEC) is inaugurated: a step forward for biomedical research in the Balearic Islands
This milestone reinforces the position of IdISBa and the Hospital Universitario de Son Espases as centres of excellence in biomedical research while promoting scientific and healthcare development in the autonomous community.
The event was attended by the Regional Minister of Health, Manuela García; the director general of Health Research, Vicenç Juan; the scientific director of IdISBa, Dr. Antònia Barceló; the managing director of IdISBa, Carlos Enrique; the manager of the University Hospital of Son Espases, Dr. Cristina Granados; Dr. Borja García-Cosío, clinical manager of the unit, as well as other authorities and professionals from the health sector.
Manuela García stressed that ‘the main advantage of this early phase trial unit is that it will benefit our patients. It will prevent patients with cancer, lymphomas, neurological pathologies such as severe asthma or neurological diseases in a very deteriorated state from having to travel to other parts of the country to test new drugs or treatments that are still in the pipeline. For them, it may mean a small light at the end of the tunnel’.
Dr. Antònia Barceló, scientific director of Idisba, expressed her deep gratitude to the patients who voluntarily participate in clinical trials: ‘Without their participation, it would not be possible to advance medical research. With the launch of this new unit, we want to improve the channels of communication and participation, so that more and more patients can access these therapeutic opportunities.
A pioneering infrastructure for clinical research in the Balearic Islands
The new phase I unit of the UBICEC, located in the +2m module of the Son Espases University Hospital, occupies 155 m² and has a hospitalisation area with two beds, a one-day hospital with three seats, nursing control and biological sample management areas and spaces for the coordination and management of clinical trials.
The activity of the unit will be directed by Dr. Francisco de Borja García-Cosío and will have a multidisciplinary team made up of medical, nursing and technical staff. This structure is complemented by the support of the IdISBa Clinical Trials Management Unit.
The creation of this unit responds to the need to provide our community with a resource to carry out highly complex clinical trials, strengthen clinical research of excellence and guarantee equitable access to innovative therapies for the Balearic population.
A boost for biomedical research and therapeutic innovation
Early-stage clinical trials are essential to assess the safety and effectiveness of new treatments. This process not only benefits patients, offering them innovative therapies that can improve their quality of life but also promotes public-private collaboration, attracting resources for research and the transfer of scientific knowledge to clinical practice.